Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,488 INR | -1.52% | +3.01% | +22.71% |
05-14 | Transcript : Neuland Laboratories Limited, Q4 2024 Earnings Call, May 14, 2024 | |
05-10 | Neuland Laboratories' Consolidated Profit Declines in Fiscal Q4 | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+22.71% | 1.01B | |
+50.70% | 795B | |
+41.96% | 627B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 294B | |
+18.02% | 245B | |
+1.27% | 222B | |
+11.95% | 215B | |
+3.68% | 160B |
- Stock Market
- Equities
- NEULANDLAB Stock
- News Neuland Laboratories Limited
- Neuland Laboratories Limited Appoints D. Saharsh Rao as Chief Financial Officer